iShares S&P GSCI Commodity-Indexed Trust financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data iShares S&P GSCI Commodity-Indexed Trust files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2.29	9.71	24.5	21.4	3.74	0.43	22.3	52.6	51.3	42.5
Operating income	-5.1	-0.16	12.6	13	-2.28	-10.4	7.52	43.7	43.1	34.3
Net income	83.7	80.4	-190	175	-184	366	391	-66.5	70	57
EPS, basic	1.43	1.05	-2.29	2.79	-3.09	4.51	4.82	-1.28	1.53	1.26
EPS, diluted	1.43	1.05	-2.29	2.79	-3.09	4.51	4.82	-1.28	1.53	1.26

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	35.3	41.8	10	31.2	20.6	41.6	5.18
Short-term investments	909	1,303	1,135	721	773	1,413	1,100	904	927	1,040

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	83.7	80.4	-190	175	-184	366	391	-66.5	70	57
Cash from operations	-259	-267	-41.7	631	-257	-206	565	184	69.6	-58.2
Purchases of investments	-5,383	-7,774	-14,886	-6,476	-3,958	-8,969	-12,150	-8,411	-5,155	-6,719
Cash from financing	286	274	9.93	-609	247	227	-602	-187	-70.5	57.2
Net change in cash	27.5	6.51	-31.8	21.2	-10.6	21	-36.4	-2.75	-0.93	-1.04

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $35.69 on September 28, 2026.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-17.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	24.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	62.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-20.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	65.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-18.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-47.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-17.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-36.1%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-183.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.

Valuation

Metric	Value	How it is calculated
Market cap	$1.03B	Share price x shares outstanding.
Enterprise value	$274.8M	Market cap + total debt - cash - short-term investments.
P/E	4.32x	Market cap / net income. Only when net income is positive.
P/OCF	2.88x	Market cap / cash from operations, when positive.
Earnings yield	23.2%	Net income / market cap (the inverse of P/E).

What was iShares S&P GSCI Commodity-Indexed Trust's revenue in fiscal 2025?

iShares S&P GSCI Commodity-Indexed Trust reported revenue of $42.5M for fiscal 2025, 17% lower than the year before.

Was iShares S&P GSCI Commodity-Indexed Trust profitable in fiscal 2025?

Yes. Net income was $57.0M, a net margin of 133.9%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to iShares S&P GSCI Commodity-Indexed Trust